Carol L Shields

Summary

Affiliation: Ocular Oncology Service
Country: USA

Publications

  1. ncbi Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma
    Carlos Bianciotto
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 119:843-9. 2012
  2. ncbi Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, PA, USA
    Retina 32:799-804. 2012
  3. ncbi Iris melanoma: features and prognosis in 317 children and adults
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J AAPOS 16:10-6. 2012
  4. ncbi Clinical survey of 3680 iris tumors based on patient age at presentation
    Carol L Shields
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 119:407-14. 2012
  5. ncbi Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on american joint committee on cancer classification
    Sanket U Shah
    Ocular Oncology Service, Wills Eye Institute, 840 Walnut St, Ste 1440, Philadelphia, PA 19107
    Arch Ophthalmol 130:159-64. 2012
  6. ncbi Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction
    Aparna Ramasubramanian
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Br J Ophthalmol 96:356-9. 2012
  7. ncbi Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, PA 19107, USA
    Ophthalmology 119:188-92. 2012
  8. ncbi The hunt for the secrets of uveal melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Clin Experiment Ophthalmol 36:277-80. 2008
  9. ncbi Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut Street, Philadelphia, PA 19107, USA
    Retina 28:1289-95. 2008
  10. ncbi Pigmented squamous cell carcinoma in situ of the conjunctiva in 5 cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 115:1673-8. 2008

Detail Information

Publications120 found, 100 shown here

  1. ncbi Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma
    Carlos Bianciotto
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 119:843-9. 2012
    ..To evaluate fluorescein angiography (FA) findings after intra-arterial chemotherapy (IAC) for retinoblastoma...
  2. ncbi Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, PA, USA
    Retina 32:799-804. 2012
    ..To study the effect of intraarterial chemotherapy (IAC) on retinoblastoma-induced retinal detachment...
  3. ncbi Iris melanoma: features and prognosis in 317 children and adults
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J AAPOS 16:10-6. 2012
    ..To evaluate iris melanoma in children versus adults...
  4. ncbi Clinical survey of 3680 iris tumors based on patient age at presentation
    Carol L Shields
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 119:407-14. 2012
    ..To report the spectrum of iris lesions based on patient age at presentation...
  5. ncbi Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on american joint committee on cancer classification
    Sanket U Shah
    Ocular Oncology Service, Wills Eye Institute, 840 Walnut St, Ste 1440, Philadelphia, PA 19107
    Arch Ophthalmol 130:159-64. 2012
    ..To evaluate the efficacy of topical interferon alfa-2b in the management of ocular surface squamous neoplasia (OSSN)...
  6. ncbi Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction
    Aparna Ramasubramanian
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Br J Ophthalmol 96:356-9. 2012
    ..These tractional features are not often found in Coats' disease treated with standard measures without bevacizumab. Caution is advised in the use of bevacizumab for patients with Coats' disease...
  7. ncbi Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, PA 19107, USA
    Ophthalmology 119:188-92. 2012
    ..To assess the efficacy of less than 3 cycles of intra-arterial chemotherapy (IAC) for retinoblastoma...
  8. ncbi The hunt for the secrets of uveal melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Clin Experiment Ophthalmol 36:277-80. 2008
    ..Currently, the most important mutation proves to be chromosome 3 monosomy, an abnormality associated with greater risk for metastatic disease...
  9. ncbi Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut Street, Philadelphia, PA 19107, USA
    Retina 28:1289-95. 2008
    ..To evaluate regression rates after plaque radiotherapy and thermotherapy of uveal melanoma with chromosome 3 monosomy versus disomy...
  10. ncbi Pigmented squamous cell carcinoma in situ of the conjunctiva in 5 cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 115:1673-8. 2008
    ..To describe 5 patients with pigmented conjunctival squamous cell carcinoma in situ...
  11. ncbi Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Ste 1440, 840 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 126:273-4. 2008
  12. ncbi Autofluorescence of choroidal nevus in 64 cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 28:1035-43. 2008
    ..To describe the autofluorescence features of choroidal nevi...
  13. ncbi Regression of extrafoveal choroidal osteoma following photodynamic therapy
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Arch Ophthalmol 126:135-7. 2008
  14. ncbi Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 115:546-552.e2. 2008
    ..To evaluate the clinical features of choroidal nevi based on patient age at presentation and to investigate features of the nevi that are predictive of patient symptoms...
  15. ncbi Autofluorescence of orange pigment overlying small choroidal melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 27:1107-11. 2007
    ..To describe the autofluorescence features of orange pigment (intracellular lipofuscin) overlying small presumed choroidal melanomas...
  16. ncbi Autofluorescence of congenital hypertrophy of the retinal pigment epithelium
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 27:1097-100. 2007
    ..To describe the autofluorescence features of CHRPE...
  17. ncbi Visual acuity in 3422 consecutive eyes with choroidal nevus
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, 840 Walnut St, Ste 1440, Philadelphia, PA 19107, USA
    Arch Ophthalmol 125:1501-7. 2007
    ..To evaluate visual acuity in eyes with choroidal nevus...
  18. ncbi Bilateral primary choroidal melanoma treated with bilateral plaque radiotherapy: a report of three cases
    M Furuta
    Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Eur J Ophthalmol 16:879-82. 2006
    ..To report three cases of bilateral primary choroidal melanoma treated with bilateral plaque radiotherapy...
  19. ncbi Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child
    Carol L Shields
    Ocular Oncology Service, Suite 1440, Wills Eye Hospital, 840 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 125:840-2. 2007
  20. ncbi Sequential bilateral solitary extramedullary plasmacytoma of the ciliary body
    Carol L Shields
    Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cornea 26:759-61. 2007
    ..To report bilateral plasmacytoma of the ciliary body in a healthy patient...
  21. ncbi Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 114:1919-24. 2007
    ..To evaluate the presence of chromosome 3 monosomy in small choroidal melanoma using fine-needle aspiration biopsy (FNAB)...
  22. ncbi Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship
    Carol L Shields
    Ocular Oncology Service, Suite 1440, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 125:1017-24. 2007
    ..To evaluate the feasibility of genetic testing of uveal melanoma using fine-needle aspiration biopsy (FNAB)...
  23. ncbi Conjunctival tumors in children
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Curr Opin Ophthalmol 18:351-60. 2007
    ..Numerous conjunctival tumors can occur in children, originating from tissues of choristomatous, epithelial, melanocytic, vascular, fibrous, xanthomatous and lymphoid. Overall, 97% prove to be benign and only 3% are malignant...
  24. ncbi Optical coherence tomography of choroidal osteoma in 22 cases: evidence for photoreceptor atrophy over the decalcified portion of the tumor
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 114:e53-8. 2007
    ..To evaluate the retinal status overlying choroidal osteoma using optical coherence tomography (OCT)...
  25. ncbi Autofluorescence of choroidal melanoma in 51 cases
    C L Shields
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Br J Ophthalmol 92:617-22. 2008
    ..To describe the autofluorescence features of choroidal melanoma...
  26. ncbi Clinical spectrum of diffuse infiltrating retinoblastoma in 34 consecutive eyes
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmology 115:2253-8. 2008
    ..To evaluate the clinical features and management of diffuse infiltrating retinoblastoma...
  27. ncbi Combined hamartoma of the retina and retinal pigment epithelium in 77 consecutive patients visual outcome based on macular versus extramacular tumor location
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmology 115:2246-2252.e3. 2008
    ..To evaluate visual outcome of eyes with combined hamartoma of the retina and retinal pigment epithelium (RPE)...
  28. ncbi Ocular melanoma: relatively rare but requiring respect
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, PA 19107, USA
    Clin Dermatol 27:122-33. 2009
    ..Eyelid and primary orbital melanoma are the least common variants. Early diagnosis from annual ocular examination by an experienced ophthalmologist and treatment strategies are reviewed...
  29. ncbi Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 127:981-7. 2009
    ..To determine features that are predictive of growth of choroidal nevi into melanoma...
  30. ncbi Sector (partial) oculo(dermal) melanocytosis in 89 eyes
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 118:2474-9. 2011
    ..To describe sector (partial) involvement of the uvea with melanocytosis...
  31. ncbi Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 129:746-50. 2011
    ..To describe the features of phacomatosis pigmentovascularis (cesioflammea type)...
  32. ncbi Intra-arterial Chemotherapy for Retinoblastoma: Report No. 1, Control of Retinal Tumors, Subretinal Seeds, and Vitreous Seeds
    Carol L Shields
    Ocular Oncology Service, Ste 1440, Wills Eye Institute, 840 Walnut St, Philadelphia, PA 19107
    Arch Ophthalmol 129:1399-406. 2011
    ..To describe tumor control following intra-arterial chemotherapy (IAC) for retinoblastoma...
  33. ncbi Intra-arterial Chemotherapy for Retinoblastoma: Report No. 2, Treatment Complications
    Carol L Shields
    Ocular Oncology Service, Ste 1440, Wills Eye Institute, 840 Walnut St, Philadelphia, PA 19107
    Arch Ophthalmol 129:1407-15. 2011
    ..To describe treatment complications following intra-arterial chemotherapy (IAC) for retinoblastoma...
  34. ncbi Iridocorneal endothelial syndrome masquerading as iris melanoma in 71 cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 129:1023-9. 2011
    ..To describe the clinical features of iridocorneal endothelial (ICE) syndrome in a group of patients referred because of suspected iris melanoma...
  35. ncbi Cytogenetic testing of iris melanoma using fine needle aspiration biopsy in 17 patients
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 31:574-80. 2011
    ..To determine the incidence of Chromosome 3 monosomy in iris melanoma using fine needle aspiration biopsy...
  36. ncbi Langerhans cell histiocytosis of the uvea with neovascular glaucoma: diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J AAPOS 14:534-7. 2010
    ..25 mg/0.05 mL) resolved the iris neovascularization, and plaque radiotherapy (brachytherapy) resolved the mass rapidly and completely, preserving the patient's visual acuity and preventing glaucoma during the 10-month follow-up...
  37. ncbi Anterior segment optical coherence tomography of conjunctival nevus
    Carol L Shields
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 118:915-9. 2011
    ..To evaluate conjunctival nevi using anterior segment optical coherence tomography (AS-OCT)...
  38. ncbi Halo nevus of the choroid in 150 patients: the 2010 Henry van Dyke Lecture
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Arch Ophthalmol 128:859-64. 2010
    ..To evaluate choroidal halo nevus...
  39. ncbi Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA, USA
    Clin Experiment Ophthalmol 38:638-43. 2010
    ..Despite its allure, intra-arterial chemotherapy should be used with caution, as in other fields of paediatric oncology it has been found to provide no advantage over intravenous chemotherapy. Time will tell...
  40. ncbi Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, USA
    Curr Opin Ophthalmol 21:203-12. 2010
    ..To provide an update on current management of retinoblastoma..
  41. ncbi Choroidal vitiligo masquerading as large choroidal nevus: a report of four cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmology 117:109-113.e3. 2010
    ..To describe 4 patients with choroidal vitiligo masquerading as large choroidal nevus...
  42. ncbi Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut St, Ste 1440, Philadelphia, PA 19107, USA
    Arch Ophthalmol 127:989-98. 2009
    ..To determine the rate of metastasis of uveal melanoma on the basis of tumor thickness in millimeters...
  43. ncbi Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors
    Carol L Shields
    The Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut St, Ste 1440, Philadelphia, Pennsylvania 19107, USA
    Arch Ophthalmol 127:282-90. 2009
    ..To evaluate retinoblastoma regression patterns following chemoreduction and adjuvant therapy...
  44. ncbi Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes
    Carol L Shields
    The Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 116:529-35. 2009
    ..To evaluate the clinical features and outcomes of eyes with peripheral exudative hemorrhagic chorioretinopathy (PEHCR) simulating choroidal melanoma...
  45. ncbi Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 116:544-551.e1. 2009
    ..To evaluate chemoreduction (CRD) for group E retinoblastoma...
  46. ncbi Postenucleation adjuvant chemotherapy with vincristine, Etoposide, and Carboplatin for the treatment of high-risk retinoblastoma
    Swathi Kaliki
    Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut St, Philadelphia, PA 19107
    Arch Ophthalmol 129:1422-7. 2011
    ..PurposeĀ  To determine the efficacy of postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin in the prevention of metastasis for patients with high-risk retinoblastoma...
  47. ncbi Practical approach to management of retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
    Arch Ophthalmol 122:729-35. 2004
    ..To present a simplified approach to management of retinoblastoma using basic clinical features...
  48. ncbi Clinical features of small choroidal melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Curr Opin Ophthalmol 13:135-41. 2002
    ..Therefore, ophthalmologists should be aware of the important factors that identify small choroidal melanoma so that early treatment and better life prognosis can be achieved for their patients...
  49. ncbi Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 900 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 120:933-40. 2002
    ..To evaluate tumor control and treatment complications following plaque radiotherapy combined with transpupillary thermotherapy for choroidal melanoma...
  50. ncbi Chemoreduction for unilateral retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, 840 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 120:1653-8. 2002
    ..To evaluate conservative management of unilateral retinoblastoma using chemoreduction and focal treatment...
  51. ncbi Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA
    Arch Ophthalmol 123:765-73. 2005
    ..To evaluate the effectiveness of chemoreduction alone and chemoreduction with thermotherapy for macular retinoblastoma...
  52. ncbi Ocular surface squamous neoplasia (squamous cell carcinoma) of the socket: management of extensive tumors with interferon
    Carol L Shields
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthal Plast Reconstr Surg 27:247-50. 2011
    ..To describe the clinical features and management of extensive ocular surface squamous neoplasia (OSSN) (squamous cell carcinoma) of the socket...
  53. ncbi Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 121:1571-6. 2003
    ..To evaluate the occurrence of new retinoblastomas in patients treated with 6 cycles of chemoreduction...
  54. ncbi Recent developments in the management of choroidal melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Philadelphia, Pennsylvania, USA
    Curr Opin Ophthalmol 15:244-51. 2004
    ..To describe recent advances in the management of choroidal melanoma...
  55. ncbi Diagnosis and management of retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas JeffersonUniversity, Philadelphia, PA 19107, USA
    Cancer Control 11:317-27. 2004
    ..Retinoblastoma is a highly malignant tumor of the eye that manifests most often in the first 3 years of life...
  56. ncbi Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Philadelphia, PA 19107, USA
    Am J Ophthalmol 138:329-37. 2004
    ..To evaluate retinoblastoma control following chemoreduction...
  57. ncbi Clinical factors in the identification of small choroidal melanoma
    Carol L Shields
    Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Can J Ophthalmol 39:351-7. 2004
    ..Therefore, ophthalmologists should be aware of the clinical factors that identify small choroidal melanoma so that early treatment and better prognosis can be achieved for their patients...
  58. ncbi Progressive enlargement of acquired retinal astrocytoma in 2 cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 111:363-8. 2004
    ..To document 2 cases of progressively enlarging retinal astrocytoma that caused exudative retinal detachment, vitreous hemorrhage, and tumor seeding, simulating retinoblastoma in 1 case and choroidal melanoma in the other...
  59. ncbi Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Arch Ophthalmol 123:1610-2. 2005
  60. ncbi Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Arch Ophthalmol 123:1658-66. 2005
    ..To evaluate choroidal osteoma for tumor growth, tumor decalcification, related choroidal neovascularization, visual acuity loss, and poor visual acuity...
  61. ncbi Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma)
    C L Shields
    Ocular Oncology Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107
    Arch Ophthalmol 119:1269-72. 2001
    ..To evaluate whether neoadjuvant intravenous chemotherapy (chemoreduction) for retinoblastoma reduces the risk for associated intracranial neuroblastic tumor (trilateral retinoblastoma)...
  62. ncbi Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Am J Ophthalmol 133:601-6. 2002
    ..To evaluate the efficacy of topical mitomycin C for extensive recurrent conjunctival and corneal squamous cell carcinoma (SCC)...
  63. ncbi Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Arch Ophthalmol 124:1196-7. 2006
  64. ncbi Optical coherence tomographic findings of combined hamartoma of the retina and retinal pigment epithelium in 11 patients
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, 840 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 123:1746-50. 2005
  65. ncbi Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy
    C L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, 900 Walnut St, Philadelphia, PA 19107, USA
    Am J Ophthalmol 132:576-8. 2001
    ..To illustrate a novel method of management for extensive conjunctival and corneal melanoma...
  66. ncbi Basic understanding of current classification and management of retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Curr Opin Ophthalmol 17:228-34. 2006
    ..The current classification and management strategies for retinoblastoma are discussed...
  67. ncbi Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients
    Mandeep S Sagoo
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 126:1515-22. 2008
    ..To evaluate tumor control with plaque radiotherapy for juxtapapillary choroidal melanoma that overhangs the optic disc...
  68. ncbi Intravitreal triamcinolone acetonide for acute radiation papillopathy
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Retina 26:537-44. 2006
    ..The long-term effects remain unknown...
  69. ncbi Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Trans Am Ophthalmol Soc 102:35-44; discussion 44-5. 2004
    ..Globe salvage is usually achieved despite tumor recurrence...
  70. ncbi Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Am J Ophthalmol 133:657-64. 2002
    ..To report the results of chemoreduction and focal therapy for retinoblastoma with determination of factors predictive of the need for treatment with external beam radiotherapy or enucleation...
  71. ncbi Early macular morphological changes following plaque radiotherapy for uveal melanoma
    Noel Horgan
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Retina 28:263-73. 2008
    ..To evaluate the time of onset and risk factors for the development of macular edema following plaque radiotherapy for uveal melanoma, using optical coherence tomography (OCT)...
  72. ncbi Retinal break and rhegmatogenous retinal detachment after transpupillary thermotherapy as primary or adjunct treatment of choroidal melanoma
    Arman Mashayekhi
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Retina 28:274-81. 2008
    ..To report the development of retinal break or rhegmatogenous retinal detachment (RRD) after transpupillary thermotherapy (TTT) as primary or adjunct treatment of choroidal melanoma...
  73. ncbi Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 113:2087-92. 2006
    ..Complications such as radiation retinopathy and mild vitreous hemorrhage should be anticipated, depending on the location, size, and extent of the tumor...
  74. ncbi Conjunctival melanoma 3 years after radiation and chemotherapy for retinoblastoma
    Amita Mahajan
    Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J Pediatr Ophthalmol Strabismus 44:300-2. 2007
    ..Excisional biopsy revealed an amelanotic melanoma of the conjunctiva with superficial orbital invasion. There has been no tumor recurrence during 20 months of follow-up...
  75. ncbi Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 120:460-4. 2002
    ..Retinal tumor and subretinal seed recurrence seems to manifest within 3 years of follow-up. Close follow-up of all patients treated with chemoreduction is warranted...
  76. ncbi The International Classification of Retinoblastoma predicts chemoreduction success
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 113:2276-80. 2006
    ..CONCLUSIONS: The ICRB can be of assistance in predicting CRD success for retinoblastoma. Additional treatment methods are necessary to salvage more group D eyes...
  77. ncbi Long-term visual outcome following chemoreduction for retinoblastoma
    Hakan Demirci
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 123:1525-30. 2005
    ..CONCLUSION: The clinical factors that predicted visual acuity of 20/40 or better were a tumor margin at least 3 mm from the foveola and optic disc and an absence of subretinal fluid...
  78. ncbi Giant choroidal nevus clinical features and natural course in 322 cases
    Helen K Li
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 117:324-33. 2010
    ..Evaluation of clinical features and natural course of giant choroidal nevi (diameter >or=10 mm)...
  79. ncbi Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction
    Hakan Demirci
    Oncology Service and the Department of Pathology, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 121:1125-31. 2003
    ..Despite the lack of viable-appearing retinoblastoma within the main tumor, enucleation was performed for viable subretinal and/or vitreous seeds in 7 cases and confirmed histopathologically...
  80. ncbi Autofluorescence of choroidal hemangioma in 34 consecutive eyes
    Aparna Ramasubramanian
    Ocular Oncology Department, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA, USA
    Retina 30:16-22. 2010
    ..The purpose of this study was to describe the autofluorescence (AF) features of choroidal hemangioma in 34 consecutive patients...
  81. ncbi Two discrete choroidal melanomas in an eye with ocular melanocytosis
    Santosh G Honavar
    Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Surv Ophthalmol 47:36-41. 2002
    ..In conclusion, multifocal choroidal melanoma is rare and may be related to underlying ocular melanocytosis...
  82. ncbi Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 109:225-34. 2002
    ..Transpupillary thermotherapy can cause damaging effects to the retina, leading to visual loss shortly after treatment...
  83. ncbi Visual improvement in an adult amblyopic eye following radiation-induced visual loss in the contralateral eye
    Ekaterini C Karatza
    Oncology Service, Wills Eye Hospital, 840 Walnut St, Philadelphia, PA 19107, USA
    Arch Ophthalmol 122:126-8. 2004
  84. ncbi Giant nodular posterior scleritis simulating choroidal melanoma and birdshot retinochoroidopathy
    J Fernando Arevalo
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmic Surg Lasers Imaging 34:403-5. 2003
    ..A diagnosis of nodular posterior scleritis was made and the minimally symptomatic patient without ocular pain was observed unless symptoms progressed. In this case, certain clinical features led to the proper diagnosis...
  85. ncbi Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 135:648-56. 2003
    ..Tumor control is 92% at 5 years, but related complications, especially cataract and elevated intraocular pressure, should be anticipated...
  86. ncbi The histopathologic effects of transpupillary thermotherapy in human eyes
    Brian P Connolly
    Retina Service, Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmology 110:415-20. 2003
    ..More extensive retinal damage occurred with applications that used energy levels higher than what have been used in the clinical setting or when the fundus was more heavily pigmented...
  87. ncbi Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 109:1838-49. 2002
    ..The large intraocular mass and associated features and radiation complications led to poor visual acuity in most patients. At 10 years follow-up, enucleation was necessary in 34% of patients, and metastasis developed in 55% of patients...
  88. ncbi Iridociliochoroidal melanoma arising from melanocytoma in a black teenager
    Helen K Li
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    J AAPOS 14:178-80. 2010
    ..The eye was enucleated, and metastatic evaluation remained negative at 5 years' follow-up. This unusual case, confirmed histopathologically, reveals that young patients with melanocytoma can have malignant transformation at an early age...
  89. ncbi Necrotic choroidal melanoma with scleritis and choroidal effusion
    Melis Palamar
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cornea 28:354-6. 2009
    ..To report a case of a choroidal melanoma that presented with painful scleritis and choroidal effusion...
  90. ncbi Resolution of advanced cystoid macular edema following photodynamic therapy for choroidal hemangioma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmic Surg Lasers Imaging 36:237-9. 2005
    ..Photodynamic therapy of choroidal hemangioma may be effective in resolving associated cystoid macular edema and improving visual acuity...
  91. ncbi Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Trans Am Ophthalmol Soc 105:43-52; discussion 52-3. 2007
    ..To evaluate the feasibility of genetic testing of uveal melanoma using fine-needle aspiration biopsy (FNAB)...
  92. ncbi Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 25:868-74. 2005
    ..CONCLUSIONS: Intravitreal triamcinolone acetonide can stabilize or improve visual acuity in some patients with radiation-induced maculopathy, but its effect might not be lasting...
  93. ncbi Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes
    Victoria M L Cohen
    Ocular Oncology Service, Wills Eye Institute, Philadelphia, Pennsylvania, USA
    Arch Ophthalmol 126:1245-51. 2008
    ..To report the efficacy of iodine I 125 plaque radiotherapy for the treatment of vasoproliferative tumors (VPTs) of the ocular fundus...
  94. ncbi Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture
    Jerry A Shields
    Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 115:511-519.e2. 2008
    ..To evaluate the clinical features and risks for transformation of conjunctival primary acquired melanosis (PAM) into melanoma...
  95. ncbi Plaque radiotherapy for choroidal melanoma encircling the optic disc (circumpapillary choroidal melanoma)
    Mandeep S Sagoo
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Arch Ophthalmol 125:1202-9. 2007
    ..To report results of plaque radiotherapy for choroidal melanoma that completely encircles the optic disc (circumpapillary melanoma)...
  96. ncbi Multifocal hypopigmented retinal pigment epithelial lesions in incontinentia pigmenti
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 26:328-33. 2006
    ..In this case, the classic cutaneous manifestations combined with the fine linear hypopigmented RPE foci were important in suggesting the diagnosis of IP...
  97. ncbi Photoreceptor loss overlying congenital hypertrophy of the retinal pigment epithelium by optical coherence tomography
    Carol L Shields
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Ophthalmology 113:661-5. 2006
    ..CONCLUSIONS: Using OCT, overlying retinal thinning and photoreceptor loss directly over CHRPE was found in 10 consecutive patients. These findings likely account for related visual field loss...
  98. ncbi Ocular surface squamous neoplasia after corneal graft
    Aparna Ramasubramanian
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Am J Ophthalmol 149:62-5. 2010
    ..To describe the clinical features and management of ocular surface squamous neoplasia (OSSN) after corneal graft...
  99. ncbi Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma
    Noel Horgan
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Retina 28:987-95. 2008
    ..To investigate the potential benefit of periocular depot triamcinolone in the prevention of macular edema after iodine 125 plaque radiotherapy for uveal melanoma...
  100. ncbi Progressive enlargement of cavity within melanoma masquerading as iris cyst
    Jonathan S Criss
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Cornea 25:863-5. 2006
    ..CONCLUSION: Cavitation can occur in ciliary body melanoma and can lead to misinterpretation as a cyst. Cavitary melanoma should be considered in the differential diagnosis of cystic lesions of the anterior segment...
  101. ncbi Bilateral retinal vasculopathy in a patient with dyskeratosis congenita
    Luiz F Teixeira
    Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA
    Arch Ophthalmol 126:134-5. 2008